Viewing StudyNCT04777357



Ignite Creation Date: 2024-05-06 @ 3:50 PM
Last Modification Date: 2024-10-26 @ 1:58 PM
Study NCT ID: NCT04777357
Status: RECRUITING
Last Update Posted: 2024-06-20
First Post: 2021-02-26

Brief Title: A Study to Assess Change in Disease Activity and Adverse Events AEs With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants 10 to 17 Years of Age With Bipolar I Disorder
Sponsor:
Organization: AbbVie

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 380
Enrollment Type: ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE3
Observational Models:
Time Perspective List:
Who Masked List: